Related Experiment Video
Updated: Aug 16, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Anticoagulation in atrial fibrillation and flutter
M F Scholten1, A S Thornton, J M Mekel
1Department of Clinical Electrophysiology, Thoraxcentre, Erasmus University Medical Centre, Rotterdam, The Netherlands. m.f.scholten@erasmusmc.nl
Insights
Atrial fibrillation and atrial flutter increase stroke risk. This review covers thromboembolism, risk assessment, and anticoagulation strategies, including around procedures like catheter ablation.
Area of Science:
- Cardiology
- Neurology
- Thrombosis Research
Background:
- Atrial fibrillation and atrial flutter are significant risk factors for ischemic stroke.
- Thromboembolism originating from the atria poses a major clinical challenge.
Purpose of the Study:
- To review the pathogenesis of thromboembolism in atrial arrhythmias.
- To discuss risk assessment and current anticoagulation strategies.
- To provide guidance on anticoagulation management around procedures like catheter ablation and cardioversion.
Main Methods:
- Comprehensive literature search on atrial fibrillation, atrial flutter, and stroke.
- Synthesis of evidence regarding thromboembolism pathogenesis and risk stratification.
- Analysis of anticoagulation efficacy and alternative therapies.
Main Results:
- Established link between atrial arrhythmias and increased stroke risk.
- Identified key factors for thromboembolic risk assessment.
- Evaluated efficacy of various anticoagulation therapies and alternatives.
- Highlighted complexities of anticoagulation around procedures.
Conclusions:
- Effective anticoagulation is crucial for stroke prevention in patients with atrial fibrillation and atrial flutter.
- Tailored anticoagulation strategies are necessary for procedures like catheter ablation and cardioversion.
- A suggested anticoagulation strategy for pulmonary vein ablation is proposed.
Abstract:
Atrial fibrillation and atrial flutter are important risk factors for stroke. Based on a literature search, pathogenesis of thromboembolism, risk assessment in patients, efficacy of anticoagulation therapy and its alternatives are discussed. Special emphasis is put on issues like paroxysmal atrial fibrillation, atrial flutter and anticoagulation surrounding catheter ablation and cardioversion. A strategy for anticoagulation around the time of pulmonary vein ablation is suggested.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Clot Retraction and Fibrinolysis
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

